VOD vs GSK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

VOD

64.8
AI Score
VS
VOD Wins

GSK

37.4
AI Score

Investment Advisor Scores

VOD

65score
Recommendation
STRONG BUY

GSK

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric VOD GSK Winner
Forward P/E 35.5872 9.7656 GSK
PEG Ratio 0.6057 6.1023 VOD
Revenue Growth 7.3% 5.3% VOD
Earnings Growth -15.4% -69.5% VOD
Tradestie Score 64.8/100 37.4/100 VOD
Profit Margin -1.0% 14.5% GSK
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY AVOID NEW MONEY VOD

Relative Price Performance (Last 90 Days)

VOD 1M: -1.6% · 3M: +6.2% GSK 1M: +3.3% · 3M: +0.0%

Current Technical Phase

VOD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $16.09

GSK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.5 · Price: $51.35

Fundamentals Snapshot

Metric VOD GSK
Market Cap — —
Forward P/E 21.0 10.4
Trailing P/E — 15.8
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.3% 0.7%
Operating Margin 0.1% 0.3%
EPS -0.14 3.17
Dividend Yield 0.03% 0.04%

Frequently Asked Questions

Based on our detailed analysis, VOD is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.